ArticleJournal of medical imaging (Bellingham, Wash.)2025
Prediction of brain metastasis progression after stereotactic radiosurgery: sensitivity to changing the definition of progression.
Article in Journal of medical imaging (Bellingham, Wash.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Machine learning (ML) has been used to predict tumor progression post-stereotactic radiosurgery (SRS) based on pre-treatment MRI for brain metastasis (BM) patients, but there is variability in the definition of what constitutes progression. We aim to measure the magnitude of the change of performance of an ML model predicting post-SRS progression when various definitions of progression were used. Approach: We collected pre- and post-SRS contrast-enhanced T1-weighted MRI scans from 62 BM patients ( Results: When we varied the follow-up period, size change metric, and TRSC labeling, the AUCs had ranges of 0.06 (0.69 to 0.75), 0.06 (0.69 to 0.75), and 0.08 (0.69 to 0.77), respectively. Radiomic feature importance remained similar. Conclusions: Variability in the definition of BM progression has a measurable impact on the performance of an MRI radiomic-based ML model predicting post-SRS progression. A consistent, clinically relevant definition of post-SRS progression across studies would enable robust comparison of proposed ML systems, thereby accelerating progress in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.